0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.61%
Positive revenue growth while 0259.HK is negative. John Neff might see a notable competitive edge here.
17.91%
Positive gross profit growth while 0259.HK is negative. John Neff would see a clear operational edge over the competitor.
66.33%
EBIT growth below 50% of 0259.HK's 719.11%. Michael Burry would suspect deeper competitive or cost structure issues.
66.33%
Positive operating income growth while 0259.HK is negative. John Neff might view this as a competitive edge in operations.
-47.50%
Negative net income growth while 0259.HK stands at 132.24%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-11.19%
Negative EPS growth while 0259.HK is at 130.15%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-47.67%
Negative diluted EPS growth while 0259.HK is at 130.15%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-40.81%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
33.34%
OCF growth at 50-75% of 0259.HK's 64.98%. Martin Whitman would question if the firm lags in monetizing sales effectively.
22.09%
FCF growth under 50% of 0259.HK's 82.92%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
30.51%
10Y revenue/share CAGR under 50% of 0259.HK's 556.26%. Michael Burry would suspect a lasting competitive disadvantage.
-1.91%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
16.37%
3Y revenue/share CAGR above 1.5x 0259.HK's 6.79%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-267.39%
Negative 10Y OCF/share CAGR while 0259.HK stands at 160.75%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-307.51%
Negative 5Y OCF/share CAGR while 0259.HK is at 119.64%. Joel Greenblatt would question the firm’s operational model or cost structure.
34.33%
3Y OCF/share CAGR under 50% of 0259.HK's 90.29%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
135.80%
Net income/share CAGR at 75-90% of 0259.HK's 152.17%. Bill Ackman would press for strategic moves to boost long-term earnings.
97.13%
Below 50% of 0259.HK's 321.75%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-59.63%
Negative 3Y CAGR while 0259.HK is 58.08%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
418.24%
Equity/share CAGR of 418.24% while 0259.HK is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
52.20%
5Y equity/share CAGR at 50-75% of 0259.HK's 90.69%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
23.32%
Below 50% of 0259.HK's 47.04%. Michael Burry suspects a serious short-term disadvantage in building book value.
-100.00%
Cut dividends over 10 years while 0259.HK stands at 150.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.76%
Our AR growth while 0259.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.93%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
5.51%
Asset growth 1.25-1.5x 0259.HK's 3.84%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
69.47%
BV/share growth above 1.5x 0259.HK's 12.49%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-22.54%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
97.36%
R&D growth of 97.36% while 0259.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
9.83%
We expand SG&A while 0259.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.